Cel-Sci Corporation short interest in 2025
In 2025, Cel-Sci Corporation's disclosed short interest ran from 6.09% of shares outstanding on 15 Jan 2025 to 4.04% on 31 Dec 2025, a change of -2.05 percentage points. The year's high was 15.09% on 15 Aug 2025 and its low 4.04% on 31 Dec 2025, averaging 7.63% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.46 days on 14 Feb 2025. Full history: Cel-Sci Corporation.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 6.09% (15 Jan 2025)
- End of year
- 4.04% (31 Dec 2025)
- Change
- -2.05 pp
- High
- 15.09% (15 Aug 2025)
- Low
- 4.04% (31 Dec 2025)
- Average
- 7.63%
- Highest days to cover
- 10.46 (14 Feb 2025)
- SEC filings marked
- 5
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 6.09% | 3.23 | 10-K filed |
| 31 Jan 2025 | 5.78% | 6.48 | |
| 14 Feb 2025 | 6.02% | 10.46 | 10-Q filed |
| 28 Feb 2025 | 7.16% | 2.50 | |
| 14 Mar 2025 | 6.37% | 7.33 | |
| 31 Mar 2025 | 7.14% | 1.82 | |
| 15 Apr 2025 | 6.93% | 2.62 | |
| 30 Apr 2025 | 7.41% | 5.39 | |
| 15 May 2025 | 8.28% | 8.14 | 10-Q filed |
| 15 Aug 2025 | 15.09% | 3.45 | 10-Q filed |
| 29 Aug 2025 | 11.14% | 2.04 | |
| 15 Sep 2025 | 10.22% | 3.12 | |
| 30 Sep 2025 | 9.59% | 4.34 | |
| 15 Oct 2025 | 8.89% | 7.94 | |
| 31 Oct 2025 | 7.65% | 4.32 | |
| 14 Nov 2025 | 6.41% | 7.91 | |
| 28 Nov 2025 | 5.52% | 7.18 | |
| 15 Dec 2025 | 5.28% | 5.78 | |
| 31 Dec 2025 | 4.04% | 4.04 | 10-K filed |
See also: Cel-Sci Corporation's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.